ASX
Chimeric Therapeutics Limited
CHM:ASX•Healthcare
Sensitive ASX Announcement
Positive pre-IND meeting with FDA for Phase 1 CAR T study
Published: 21/03/23, 09:55am (AEST)•3 pages